How Merck Is Prioritizing Diversity in Clinical Trials and Why It's So Important Life Science Investing News
Merck to Hold Fourth-Quarter and Full-Year 2022 Sales and Earnings Conference Call February 2 Pharmaceutical Investing
Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference Pharmaceutical Investing
Gilead Sciences: Connecting Breast Cancer Education to Community: Equal Hope Pharmaceutical Investing
Aurinia Announces LUPKYNIS® Patent Challenge Settlement Reached With Sun Pharmaceuticals Pharmaceutical Investing
European Medicines Agency Validates Marketing Authorization Application For Trodelvy® For Pre-treated HR+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies Pharmaceutical Investing
Bristol Myers Squibb to Present at J.P. Morgan's 41st Annual Healthcare Conference Pharmaceutical Investing
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York Pharmaceutical Investing
